Table 3.
Measure | Baseline, mean (SD) | Treatment termination, mean (SD) | 3-month follow-up, mean (SD) | Baseline to follow-up | Baseline to termination | Cohen d | ||
|
|
|
|
F test (df) | P value | Post hoc t test (df) | P value |
|
SFSa total | 108.00 (7.13) | 110.13 (7.95) | 108.23 (7.29) | 2.56 (2) | .09 | −2.52 (30) | .02 | 0.44 |
QLS-IRb | 2.60 (1.36) | 2.90 (1.15) | 2.70 (1.25) | 1.13 (2) | .33 | −1.33 (30) | .19 | 0.24 |
BPRSc positive symptoms | 2.44 (0.70) | 2.22 (0.78) | 2.14 (0.76) | 3.74 (2) | .03 | 2.49 (30) | .02 | 0.45 |
CAINS-MAPd | 1.64 (0.70) | 1.71 (0.60) | 1.71 (0.77) | 0.19 (2) | .83 | −0.65 (30) | .52 | 0.12 |
aSFS: Social Functioning Scale.
bQLS-IR: Quality of Life Scale–Interpersonal Relations.
cBPRS: Brief Psychiatric Rating Scale.
dCAINS-MAP: Clinical Assessment Interview for Negative Symptoms-Motivation and Pleasure.